In vitro activity of the orally bioavailable ceftibuten/VNRX-7145 (VNRX-5236 etzadroxil) combination against a challenge set of Enterobacterales pathogens carrying molecularly characterized β-lactamase genes is a research paper published in Journal of Antimicrobial Chemotherapy (2021). On theSindex it has a DataRank of 0. It has been cited 13 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH
Grant: 1R01AI111539
NIAID
Grant: HHSN272201600029C
NIAID NIH HHS
Grant: R01 AI111539
National Institutes of Health
Grant: 5R01AI111539-03
Broad-spectrum, Orally Bioavailable Beta-lactamase Inhibitors for Biodefense
Venatorx Pharmaceuticals Inc.
Influential Citations
1
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals